Roka Bioscience, Inc. (NASDAQ:ROKA) major shareholder Orbimed Advisors Llc sold 14,300 shares of the business’s stock in a transaction dated Thursday, August 24th. The shares were sold at an average price of $1.50, for a total transaction of $21,450.00. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Major shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.
Orbimed Advisors Llc also recently made the following trade(s):
- On Wednesday, August 23rd, Orbimed Advisors Llc sold 1,100 shares of Roka Bioscience stock. The shares were sold at an average price of $1.50, for a total transaction of $1,650.00.
- On Tuesday, August 22nd, Orbimed Advisors Llc sold 75,276 shares of Roka Bioscience stock. The shares were sold at an average price of $1.52, for a total transaction of $114,419.52.
Roka Bioscience, Inc. (NASDAQ ROKA) traded down 3.33% on Friday, reaching $1.45. 67,844 shares of the company’s stock were exchanged. Roka Bioscience, Inc. has a 12 month low of $0.58 and a 12 month high of $7.37. The firm has a 50-day moving average of $2.28 and a 200-day moving average of $3.21. The firm’s market capitalization is $7.26 million.
A hedge fund recently raised its stake in Roka Bioscience stock. Sabby Management LLC boosted its position in Roka Bioscience, Inc. (NASDAQ:ROKA) by 6.5% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 389,136 shares of the medical research company’s stock after buying an additional 23,916 shares during the period. Sabby Management LLC owned approximately 7.77% of Roka Bioscience worth $1,374,000 as of its most recent SEC filing. Institutional investors own 64.11% of the company’s stock.
About Roka Bioscience
Roka Bioscience, Inc is a molecular diagnostics company. The Company is focused on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens under the Atlas brand name. The Company offers Atlas Detection Assays and Atlas instrument in the North American food safety testing market and has rights to develop and commercialize its molecular testing solutions for a range of other industrial applications.
Receive News & Ratings for Roka Bioscience Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roka Bioscience Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
